RNA-seq of human osteoclasts treated with anti-MDA or control antibodies
Our aim was to understand how the monoclonal anti-malondialdehyde modified protein antibody 146+:01G07 (originally obtained from a synovial B cell from a rheumatoid arthritis patient) modulates osteoclast development.